260 related articles for article (PubMed ID: 33975517)
21. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
22. miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway.
Li R; Hu Z; Wang Z; Zhu T; Wang G; Gao B; Wang J; Deng X
J Clin Lab Anal; 2021 Dec; 35(12):e24078. PubMed ID: 34708891
[TBL] [Abstract][Full Text] [Related]
23. CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis.
Liu K; Wang BJ; Han W; Chi CH; Gu C; Wang Y; Fu X; Huang W; Liu Z; Song X
Oncogene; 2020 Apr; 39(15):3075-3088. PubMed ID: 32066878
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
Li C; Zhang J; Zhou Y; Li B
Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
[TBL] [Abstract][Full Text] [Related]
27. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
28. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis.
Hong S; Li Q; Yang Y; Jing D; Zhu F
Mol Biotechnol; 2022 Feb; 64(2):144-155. PubMed ID: 34550549
[TBL] [Abstract][Full Text] [Related]
29. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
30. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
He S; Wang X; Zhang J; Zhou F; Li L; Han X
Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
32. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
33. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.
Liu R; Yang X
BMC Cancer; 2021 Oct; 21(1):1163. PubMed ID: 34715819
[TBL] [Abstract][Full Text] [Related]
34. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
36. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
37. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-590-5p Inhibits Intestinal Inflammation by Targeting YAP.
Yu M; Luo Y; Cong Z; Mu Y; Qiu Y; Zhong M
J Crohns Colitis; 2018 Jul; 12(8):993-1004. PubMed ID: 29912317
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p.
Gao ZQ; Wang JF; Chen DH; Ma XS; Yang W; Zhe T; Dang XW
Biomed Pharmacother; 2018 Jan; 97():809-817. PubMed ID: 29112934
[TBL] [Abstract][Full Text] [Related]
40. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]